Tim Opler

Tim Opler is a seasoned investment banker specializing in the biotech industry, currently serving as a Managing Director at Stifel Institutional since March 2023. Prior experience includes a Principal position at Torreya Partners, focusing on pharmaceuticals, disease diagnostics, and medical technology. Tim Opler held various prominent roles such as Vice President of Strategy at FibroGen and Managing Director in Healthcare Banking at Credit Suisse First Boston. Additional roles include Director positions at WR Hambrecht + Co and Deutsche Bank, as well as academic appointments as Assistant Professor at Ohio State University and Southern Methodist University. Tim Opler began a career in economics as an Associate at FineEcon and a Statistical Analyst at RAND Corporation, culminating in robust educational credentials with a Ph.D. in Economics from UCLA and a BS in Economics and Philosophy from Florida State University.